Location:Room 14c (ICM, Level 1)
Clinical relevance of experimental therapy studies will be discussed and clinical relevance assessed. Targeting tumour metabolism is a novel innovative strategy for prostate cancer. The potential of novel compounds will be presented in the session.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
Institutes: 1Kaplan Medical Center, Dept. of Urology, Rehovot, Israel, 2The Weizmann Institute of Science, Dept. of Plant and Environmental Sciences, Rehovot, Israel, 3The Weizmann Institute of Science, Dept. of Biological Regulation, Rehovot, Israel, 4Memorial Sloan-Kettering Cancer Center, Dept. of Surgery, New York, United States of America